GO:0120020 cholesterol transfer activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120020 cholesterol transfer activity describes the molecular function of removing cholesterol from a membrane or lipid particle, transporting it through the aqueous phase within a hydrophobic pocket, and delivering it to an acceptor membrane or lipid particle.
• This activity is essential for steroid hormone synthesis, membrane homeostasis, and cellular cholesterol trafficking, and its dysfunction is linked to cancer, neurodegeneration, and cardiovascular disease [1,3,5].
• Key proteins executing cholesterol transfer include STARD1, STARD3, NPC1, NPC2, ABCA1, and SR-BI, which mediate distinct steps of cholesterol movement between organelles and lipoproteins [4,5].
• Cholesterol transfer activity is regulated by hormonal signals (e.g., ACTH), nutrient sensors (mTORC1), and inter-organelle contact sites, ensuring cholesterol delivery matches cellular demand [5,7].
• Dysregulated cholesterol transfer contributes to CD8+ T cell exhaustion in tumors, macrophage-driven vascular inflammation, and osteoarthritis progression [1,2,3].
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of cholesterol transfer genes in health and disease [1,5].
Description
Cholesterol is an essential lipid that must be moved between membranes and organelles to support membrane integrity, steroidogenesis, and signaling. The Gene Ontology molecular function GO:0120020, cholesterol transfer activity, captures the protein-driven process of extracting cholesterol from a donor membrane or lipid particle, shielding it in a hydrophobic pocket during transit through the aqueous phase, and depositing it into an acceptor membrane or lipid particle. This activity is distinct from cholesterol biosynthesis or passive diffusion and is mediated by specialized carrier proteins and transporters [4,5]. Understanding cholesterol transfer activity is critical because defects in this process underlie disorders ranging from Niemann-Pick type C disease to atherosclerosis and cancer [3,5]. In the tumor microenvironment, cholesterol transfer supports CD8+ T cell exhaustion, highlighting its role in immune evasion. In cartilage, mitochondrial cholesterol relay exacerbates osteoarthritis, linking this molecular function to degenerative joint disease. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models used to study cholesterol transfer activity.
cholesterol transfer activity At A Glance
| GO ID | GO:0120020 |
|---|---|
| GO term | cholesterol transfer activity |
| Ontology | molecular_function |
| Synonym | cholesterol carrier activity, cholesterol transporter activity, intermembrane cholesterol transfer activity |
| Major function | Removes cholesterol from a donor membrane or lipid particle, transports it through the aqueous phase in a hydrophobic pocket, and delivers it to an acceptor membrane or lipid particle. |
| Related cellular processes | Steroid hormone synthesis, membrane trafficking, cholesterol homeostasis, inter-organelle communication [4,5,7]. |
| Key regulators | ACTH signaling, mTORC1, NPC1/NPC2, STARD proteins [5,7]. |
| Disease relevance | Niemann-Pick type C disease, atherosclerosis, cancer, osteoarthritis [2,3,5]. |
What Is GO:0120020?
Cholesterol transfer activity (GO:0120020) is defined as the molecular function that removes cholesterol from a membrane or a monolayer lipid particle, transports it through the aqueous phase while protected in a hydrophobic pocket, and brings it to an acceptor membrane or lipid particle. This activity requires a protein or protein complex that binds cholesterol, shields it from the aqueous environment, and facilitates its directional movement between distinct lipid bilayers or particles [4,5]. It is a carrier-type function, not a catalytic one, and is often coupled to energy-dependent processes or organelle contact sites.
Why Is cholesterol transfer activity Important in Cell Biology?
Cholesterol transfer activity is fundamental to cellular cholesterol homeostasis and specialized functions such as steroidogenesis. Without efficient transfer, cholesterol accumulates in donor membranes or fails to reach acceptor compartments, leading to cellular toxicity and disease [4,5]. This activity is also co-opted in pathological states: tumors promote cholesterol transfer to exhaust CD8+ T cells, and macrophages use cholesterol transfer to drive vascular inflammation [1,3]. Thus, understanding GO:0120020 provides mechanistic insight into both normal physiology and multiple human diseases.
• Enables steroid hormone production by delivering cholesterol to mitochondrial CYP11A1 [4,7].
• Maintains membrane cholesterol asymmetry and organelle function.
• Supports immune cell function and is implicated in CD8+ T cell exhaustion in tumors.
• Drives macrophage-derived 25-hydroxycholesterol production and atherogenesis.
• Contributes to osteoarthritis via mitochondrial cholesterol relay.
• Is defective in Niemann-Pick type C disease, causing lysosomal cholesterol accumulation.
• Regulates mTORC1 signaling through ER-lysosome contacts.
• Provides targets for therapeutic intervention in cardiovascular and metabolic diseases.
• Can be studied with CRISPR knockout and knock-in models for causal gene validation [1,5].
• Involves extracellular vesicle loading, relevant for drug delivery.
What Happens During cholesterol transfer activity?
Cholesterol extraction from donor membrane
In simple terms: A protein grabs cholesterol from one membrane.
The first step in cholesterol transfer activity is the recognition and extraction of cholesterol from a donor membrane or lipid particle. Proteins such as STARD1 bind cholesterol in a hydrophobic pocket, removing it from the lipid bilayer. This extraction is often facilitated by membrane contact sites that bring donor and acceptor membranes into close apposition.
Aqueous phase transport
In simple terms: The protein carries cholesterol through water without letting it dissolve.
Once bound, the cholesterol molecule is shielded from the aqueous environment by the hydrophobic pocket of the carrier protein. This allows directional transport through the cytosol or intermembrane space. The carrier protein undergoes conformational changes to release cholesterol at the acceptor membrane.
Delivery to acceptor membrane or lipid particle
In simple terms: Cholesterol is handed off to the target membrane.
The final step is the transfer of cholesterol to an acceptor membrane or lipid particle, such as the inner mitochondrial membrane for steroidogenesis or the plasma membrane for efflux [4,7]. This delivery may require accessory proteins like NPC2 or ABCA1. The directionality and efficiency of transfer are regulated by cellular signals.
Regulation by organelle contact sites
In simple terms: Organelles touch each other to pass cholesterol.
Membrane contact sites between the ER and lysosomes or mitochondria facilitate cholesterol transfer by maintaining close proximity and enabling protein-protein interactions. For example, ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signaling in Niemann-Pick type C. These contact sites are dynamic and respond to cellular cholesterol levels.
Key Genes Involved in GO:0120020 cholesterol transfer activity
The following genes encode proteins that directly mediate or regulate cholesterol transfer activity (GO:0120020).
| Gene | Major Role | Research Relevance |
|---|---|---|
| STARD1 | Binds and transfers cholesterol to mitochondrial CYP11A1 for steroidogenesis | Knockout models show impaired steroid hormone synthesis |
| STARD3 | Transfers cholesterol between endosomes and ER | Implicated in cholesterol trafficking and cancer |
| NPC1 | Mediates cholesterol export from lysosomes | Mutations cause Niemann-Pick type C disease |
| NPC2 | Binds cholesterol in lysosomal lumen and transfers to NPC1 | Defects lead to lysosomal cholesterol accumulation |
| ABCA1 | Transfers cholesterol and phospholipids to apolipoproteins | Knockout causes Tangier disease and atherosclerosis |
| SR-BI | Mediates selective cholesterol uptake from HDL | Regulates reverse cholesterol transport |
| CYP11A1 | Converts cholesterol to pregnenolone after transfer | Requires cholesterol transfer for activity |
| ACAT1 | Esterifies cholesterol after transfer | Regulates free cholesterol pools |
| mTORC1 | Senses cholesterol at ER-lysosome contacts | Drives growth signaling in NPC disease |
| Tak1 | Licenses mitochondrial transfer from astrocytes to POMC neurons | Links cholesterol transfer to glucose homeostasis |
| 25-hydroxylase (CH25H) | Produces 25-hydroxycholesterol from transferred cholesterol | Promotes vascular inflammation |
| CD8+ T cells (not a gene) | Cholesterol transfer induces exhaustion | Target for cancer immunotherapy |
| Mitochondrial cholesterol relay proteins | Relay cholesterol signals in osteoarthritis | Potential targets for osteoarthritis |
| Extracellular vesicle proteins | Load cholesterol and porphyrins into vesicles | Used for drug delivery |
| ACTH receptor (MC2R) | Stimulates cholesterol transfer in adrenocortical cells | Regulates steroidogenesis |
| POMC neurons | Receive mitochondrial transfer for cholesterol homeostasis | Central to energy balance |
| Macrophage cholesterol transporters | Promote 25-hydroxycholesterol production | Drive atherogenesis |
| Lysosomal cholesterol transporters | Export cholesterol from lysosomes | Defective in NPC disease |
How Is cholesterol transfer activity Regulated?
Cholesterol transfer activity is regulated at multiple levels. Hormonal signals such as ACTH stimulate cholesterol transfer from the plasma membrane to mitochondria in adrenocortical cells, a process required for steroidogenesis. Nutrient sensors like mTORC1 sense cholesterol at ER-lysosome contact sites, and dysregulation of this sensing drives aberrant growth signaling in Niemann-Pick type C disease. Additionally, intercellular transfer via mitochondria from astrocytes to POMC neurons is licensed by Tak1 and maintains glucose and cholesterol homeostasis. These regulatory mechanisms ensure cholesterol delivery matches cellular demand and prevent toxic accumulation [4,5].
cholesterol transfer activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C disease | Knockout iPSC-derived neurons |
| ABCA1 | Tangier disease and atherosclerosis | Macrophage-specific knockout mice |
| STARD1 | Lipoid congenital adrenal hyperplasia | Knockout adrenal cell lines |
| CH25H | Vascular inflammation and atherogenesis | Knockout macrophages |
| Mitochondrial relay proteins | Osteoarthritis | Cartilage-specific knockout mice |
Cancer and immune evasion
Cholesterol transfer activity contributes to CD8+ T cell exhaustion in the tumor microenvironment. Increased cholesterol transfer induces exhaustion markers and impairs antitumor immunity, suggesting that targeting cholesterol transfer could enhance immunotherapy.
Cardiovascular disease and atherosclerosis
Macrophage-derived 25-hydroxycholesterol, produced from transferred cholesterol, promotes vascular inflammation, atherogenesis, and lesion remodeling. This links cholesterol transfer activity to the pathogenesis of atherosclerosis.
Neurodegeneration and Niemann-Pick type C
Defects in lysosomal cholesterol transfer cause Niemann-Pick type C disease, characterized by cholesterol accumulation and neurodegeneration. ER-lysosome contacts enable cholesterol sensing by mTORC1, and their dysfunction drives aberrant growth signaling in NPC.
Osteoarthritis
Mitochondria relay cholesterol signals that exacerbate osteoarthritis in mice. This mitochondrial cholesterol transfer pathway represents a potential therapeutic target for osteoarthritis.
From cholesterol transfer activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NPC1 impair cholesterol transfer? | NPC1 knockout cell line |
| Does a point mutation in STARD1 affect cholesterol binding? | STARD1 point-mutation knock-in |
| Can we tag endogenous NPC2 to track cholesterol transfer? | NPC2 tagged knock-in |
| Does overexpression of ABCA1 increase cholesterol efflux? | ABCA1 overexpression cell line |
| Does macrophage CH25H knockout reduce atherosclerosis? | CH25H knockout mice |
| Does mitochondrial cholesterol relay require Tak1? | Tak1 conditional knockout |
How to Study the cholesterol transfer activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BODIPY-cholesterol transfer assay | Real-time cholesterol movement between membranes | Protein-mediated transfer kinetics |
| Proximity ligation assay | Organelle contact sites | ER-lysosome contacts |
| CRISPR knockout screen | Genes required for cholesterol transfer | Identify novel regulators |
| Lipidomics (LC-MS) | Cholesterol and oxysterol levels | Validate transfer defects |
| Live-cell imaging | Cholesterol distribution and dynamics | Track transfer in real time |
| Immunoprecipitation | Protein-protein interactions | Identify transfer complexes |
| Extracellular vesicle loading assay | Cholesterol loading into vesicles | Drug delivery applications |
Fluorescence-based cholesterol transfer assays
Fluorescent cholesterol analogs such as dehydroergosterol or BODIPY-cholesterol are used to monitor transfer between membranes in real time. These assays can measure the kinetics of cholesterol extraction and delivery by purified proteins or in cell lysates.
Organelle contact site imaging
High-resolution microscopy techniques, including electron microscopy and proximity ligation assays, visualize membrane contact sites where cholesterol transfer occurs. These methods reveal dynamic ER-lysosome and ER-mitochondria contacts.
CRISPR screening for cholesterol transfer regulators
Genome-wide CRISPR knockout screens can identify genes required for cholesterol transfer activity. Cells are challenged with cholesterol depletion or labeled cholesterol, and transfer is measured by flow cytometry or imaging [1,5].
Lipidomics and mass spectrometry
Mass spectrometry quantifies cholesterol and its metabolites (e.g., 25-hydroxycholesterol) in subcellular fractions, providing a readout of transfer efficiency. This approach is useful for validating knockout phenotypes.
How CRISPR Can Be Used to Study GO:0120020 cholesterol transfer activity
Knockout
CRISPR knockout of genes such as NPC1, ABCA1, or STARD1 abolishes cholesterol transfer activity, leading to cholesterol accumulation or impaired steroidogenesis. These models are used to confirm the essential role of specific genes in GO:0120020 [4,5].
Point Mutation
Point mutations in cholesterol-binding residues of STARD1 or NPC2 can disrupt transfer without affecting protein stability. Such models help dissect the molecular determinants of cholesterol binding and transfer.
Knock-in
Knock-in of tagged versions of NPC1 or STARD3 allows visualization and purification of transfer complexes. This approach enables tracking of endogenous cholesterol transfer in live cells.
Overexpression
Overexpression of ABCA1 or SR-BI increases cholesterol efflux and transfer to acceptors. These models are used to study gain-of-function effects and potential therapeutic targets.
How EDITGENE Supports cholesterol transfer activity Research
Researchers studying cholesterol transfer activity-related genes often need to determine whether a candidate gene is causally involved in cholesterol movement between membranes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cholesterol transfer activity research.
Frequently Asked Questions About cholesterol transfer activity
What is cholesterol transfer activity?
Cholesterol transfer activity (GO:0120020) is a molecular function that removes cholesterol from a membrane or lipid particle, transports it through the aqueous phase in a hydrophobic pocket, and delivers it to an acceptor membrane or lipid particle.
What genes are involved in cholesterol transfer activity?
Key genes include STARD1, STARD3, NPC1, NPC2, ABCA1, SR-BI, and CYP11A1, among others [4,5].
How is cholesterol transfer activity regulated?
It is regulated by hormonal signals like ACTH, nutrient sensors like mTORC1, and organelle contact sites [5,7].
What diseases are associated with defective cholesterol transfer?
Niemann-Pick type C disease, atherosclerosis, cancer, and osteoarthritis are linked to defects in cholesterol transfer [1,2,3,5].
What is the role of NPC1 in cholesterol transfer?
NPC1 mediates cholesterol export from lysosomes; mutations cause Niemann-Pick type C disease.
How can I study cholesterol transfer activity in the lab?
Use fluorescent cholesterol analogs, organelle contact site imaging, CRISPR screens, and lipidomics [4,5].
What is the difference between cholesterol transfer and cholesterol transport?
Cholesterol transfer activity specifically refers to protein-mediated movement of cholesterol between membranes, while transport can be broader.
Can CRISPR be used to study cholesterol transfer genes?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect gene function in cholesterol transfer [1,5].
What is the role of STARD1 in cholesterol transfer?
STARD1 binds cholesterol and transfers it to mitochondrial CYP11A1 for steroidogenesis.
How does cholesterol transfer affect immune cells?
Cholesterol transfer induces CD8+ T cell exhaustion in the tumor microenvironment, impairing antitumor immunity.
Conclusion
Cholesterol transfer activity (GO:0120020) is a specialized molecular function essential for cholesterol homeostasis, steroidogenesis, and inter-organelle communication. Its dysregulation contributes to cancer, cardiovascular disease, neurodegeneration, and osteoarthritis. Advances in CRISPR-based models and imaging techniques continue to unravel the precise mechanisms and regulatory networks governing this activity. Targeting cholesterol transfer pathways holds therapeutic promise for a range of human diseases.
References
- 1. Ma X et al.. 2019. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment.. Cell Metab 30(1):143-156.e5 PMID: 31031094
- 2. Ma Y et al.. 2025. Mitochondria relay cholesterol signal exacerbates osteoarthritis in mice.. Nat Commun 16(1):10123 PMID: 41257852
- 3. Canfrán-Duque A et al.. 2023. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.. Circulation 147(5):388-408 PMID: 36416142
- 4. Stocco DM. 2000. Intramitochondrial cholesterol transfer.. Biochim Biophys Acta 1486(1):184-97 PMID: 10856721
- 5. Lim CY et al.. 2019. ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type C.. Nat Cell Biol 21(10):1206-1218 PMID: 31548609
- 6. Yin K et al.. 2024. Tak1 licenses mitochondrial transfer from astrocytes to POMC neurons to maintain glucose and cholesterol homeostasis.. Cell Rep 43(12):114983 PMID: 39565693
- 7. Kimura T. 1981. ACTH stimulation on cholesterol side chain cleavage activity of adrenocortical mitochondria. Transfer of the stimulus from plasma membrane to mitochondria.. Mol Cell Biochem 36(2):105-22 PMID: 6264282
- 8. Fuhrmann G et al.. 2015. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins.. J Control Release 205:35-44 PMID: 25483424
